Albemarle insider files Form 144 to sell 38,531 shares
Albemarle (ALB) reported a proposed insider sale under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Albemarle (ALB) reported a proposed insider sale under Rule 144. The notice covers up to 38,531 common shares, with an aggregate market value of $3,733,079.56, to be executed through Merrill Lynch. The approximate sale date listed is 11/07/2025.
The shares were acquired as stock awards on 08/09/2019 from Albemarle. A baseline figure shows 117,697,540 shares outstanding. This filing is a notice of potential sales by an affiliate and does not itself execute a transaction.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Albemarle (ALB) disclose in this Form 144?
Who is the broker for the proposed Albemarle Form 144 sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.